Barbara Ridolfi

researcher

Barbara Ridolfi is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-6443-5500
P1053ResearcherIDD-7967-2016

P735given nameBarbaraQ153957
BarbaraQ153957
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q41318201Antigenicity, immunogenicity and passive protection induced by immunization of mice with baculovirus-expressed VP7 protein from rhesus rotavirus
Q38915583CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
Q71709184Comparison of capillary blood versus venous blood samples in the assessment of immunity to measles
Q73416485Cross-reactivity between the major Parietaria allergen and rotavirus VP4 protein
Q34978901HIV-1 Tat-based vaccines: from basic science to clinical trials
Q34477471HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies
Q35232797HPV-E7 delivered by engineered exosomes elicits a protective CD8⁺ T cell-mediated immune response
Q36498248IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer
Q39398034Infection of a simian B cell line by human and simian immunodeficiency viruses
Q51998598Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys.
Q73594074Measles vaccine in egg allergic children: poor immunogenicity of the Edmoston-Zagreb strain
Q24674143Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors
Q35700273On the role of interferon regulatory factors in HIV-1 replication.
Q74465301Seroepidemiological evaluation of 1989-91 mass vaccination campaigns against measles, in Italy
Q56897975Tat protein vaccination of cynomolgus macaques influences SHIV-89.6P cy243 epitope variability
Q37539231The CD8⁺ T Cell-Mediated Immunity Induced by HPV-E6 Uploaded in Engineered Exosomes Is Improved by ISCOMATRIXTM Adjuvant.
Q33769629The reverse transcription inhibitor abacavir shows anticancer activity in prostate cancer cell lines

Search more.